SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-073693
Filing Date
2011-08-05
Accepted
2011-08-05 16:25:07
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a57348e10vq.htm 10-Q 403951
2 EX-31.1 a57348exv31w1.htm EX-31.1 9177
3 EX-31.2 a57348exv31w2.htm EX-31.2 9447
4 EX-32 a57348exv32.htm EX-32 6121
10 GRAPHIC a57348a5734801.gif GRAPHIC 55408
  Complete submission text file 0000950123-11-073693.txt   1666387

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT halo-20110630.xml EX-101.INS 177676
6 EX-101 SCHEMA DOCUMENT halo-20110630.xsd EX-101.SCH 9369
7 EX-101 CALCULATION LINKBASE DOCUMENT halo-20110630_cal.xml EX-101.CAL 23295
8 EX-101 LABELS LINKBASE DOCUMENT halo-20110630_lab.xml EX-101.LAB 90961
9 EX-101 PRESENTATION LINKBASE DOCUMENT halo-20110630_pre.xml EX-101.PRE 58457
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 111014535
SIC: 2836 Biological Products, (No Diagnostic Substances)